当前位置: 首页 > 详情页

Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Beijing Neurosurgical Institute, Capital Medical University, Beijing, China [2]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [3]Department of Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [4]Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [5]Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China [6]Chinese Academy of Sciences, Institute of Automation, Beijing, China
出处:
ISSN:

关键词: gliomas prognosis genetics magnetic resonance imaging biomarkers

摘要:
Objective: We aimed to identify a radiomic signature to be used as a noninvasive biomarker of prognosis in patients with lower-grade gliomas (LGGs) and to reveal underlying biological processes through comprehensive radiogenomic investigation. Methods: We extracted 55 radiomic features from T2-weighted images of 233 patients with LGGs (training cohort: n = 85; validation cohort: n = 148). Univariate Cox regression and linear risk score formula were applied to generate a radiomic-based signature. Gene ontology analysis of highly expressed genes in the high-risk score group was conducted to establish a radiogenomic map. A nomogram was constructed for individualized survival prediction. Results: The six-feature radiomic signature stratified patients in the training cohort into low- or high-risk groups for overall survival (P = 0.0018). This result was successfully verified in the validation cohort (P = 0.0396). Radiogenomic analysis revealed that the prognostic radiomic signature was associated with hypoxia, angiogenesis, apoptosis, and cell proliferation. The nomogram resulted in high prognostic accuracy (C-index: 0.92, C-index: 0.70) and favorable calibration for individualized survival prediction in the training and validation cohorts. Conclusions: Our results suggest a great potential for the use of radiomic signature as a biological surrogate in providing prognostic information for patients with LGGs.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 生物
小类 | 3 区 细胞生物学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 细胞生物学 3 区 老年医学
JCR分区:
出版当年[2016]版:
Q2 CELL BIOLOGY
最新[2023]版:
Q2 CELL BIOLOGY Q2 GERIATRICS & GERONTOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
通讯作者:
通讯机构: [1]Beijing Neurosurgical Institute, Capital Medical University, Beijing, China [2]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [5]Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院